| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 19.696 | 27.402 | 29.060 | 25.283 | 12.360 | 4.465 | 5.802 | 7.564 | 7.460 | 9.187 |
| Total Income - EUR | 19.984 | 27.507 | 29.084 | 25.428 | 17.384 | 4.530 | 5.892 | 7.599 | 7.460 | 9.187 |
| Total Expenses - EUR | 6.575 | 5.145 | 6.428 | 7.927 | 3.763 | 2.329 | 2.551 | 8.507 | 12.571 | 13.443 |
| Gross Profit/Loss - EUR | 13.409 | 22.361 | 22.656 | 17.501 | 13.621 | 2.200 | 3.342 | -908 | -5.111 | -4.256 |
| Net Profit/Loss - EUR | 12.805 | 21.608 | 21.785 | 16.739 | 13.099 | 2.064 | 3.165 | -1.107 | -5.111 | -4.351 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Algomed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 9.298 | 6.777 | 3.767 | 1.373 | 662 | 275 | 157 | 29.258 | 20.599 | 12.008 |
| Current Assets | 34.114 | 32.677 | 35.562 | 32.588 | 45.741 | 18.358 | 21.228 | 6.268 | 11.114 | 7.739 |
| Inventories | 0 | 0 | 77 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 264 | 2.447 | 1.096 | 761 | 1.086 | 1.193 | 1.204 | 1.244 | 1.671 | 2.119 |
| Cash | 33.850 | 30.230 | 34.390 | 31.827 | 44.654 | 17.165 | 20.023 | 5.025 | 9.443 | 5.619 |
| Shareholders Funds | 43.412 | 39.454 | 39.329 | 33.961 | 29.988 | 18.633 | 21.385 | 20.345 | 15.172 | 10.736 |
| Social Capital | 1.170 | 1.158 | 1.138 | 1.117 | 1.096 | 1.075 | 1.051 | 1.054 | 1.051 | 1.045 |
| Debts | 0 | 0 | 0 | 0 | 16.414 | 0 | 0 | 15.182 | 16.541 | 9.011 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Algomed Srl